Curis, Inc…announced that it will host a webcast on Wednesday, July 22 at 8:30 a.m. ET to…provide updated guidance on year-end data in the TakeAim CLL study, its ongoing Phase 2 study in Chronic Lymphocytic Leukemia

emavusertib (CA-4948) - Curis

Jul 22, 2026